Public health and budget impact of probiotics on common respiratory tract infections: A modelling study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Lenoir Wijnkoop, Irene ^a,b   Gerlier, Laetitia ^c   Bresson, Jean Louis ^d   Le Pen, Claude ^e   Berdeaux, Gilles ^c,f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Danone   (France)

^c IMS HEOR Vilvoorde B 1800   (Belgium)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITÉ PARIS DAUPHINE   (France)

^f University of Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; BUDGET; CHILD; COMMUNITY LIVING; COST CONTROL; DISEASE DURATION; DRUG USE; FEMALE; FRANCE; GENDER; HEALTH CARE UTILIZATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEASONAL VARIATION; SIMULATION; MARKOV CHAIN; MIDDLE AGED; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BUDGETS; CHILD; CHILD, PRESCHOOL; HUMANS; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; PROBIOTICS; PUBLIC HEALTH; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; YOUNG ADULT;

EID: 84928911705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122765     Document Type: Article

References (54)

1. Eccles R. Understanding the symptoms of the common cold and influenza. The Lancet Infectious Diseases 2005; 5, 718-725. PMID: 16253889
2. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000; 3, 1166-1169.
3. Navarro-Mari JM, Perez-Ruiz M, Cantudo-Munoz P, Petit-Gancedo C, Jimenez-Valera M, Rosa-Fraile M. Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study. Journal of clinical epidemiology 2005; 58, 275-279. PMID: 15768487
4. Mäkelä MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimäki M, et al. Viruses and bacteria in the etiology of the CC. J Clin Microbiol 1998; 36, 539-542. PMID: 9466772
5. Arroll B. Common cold. Am Fam Physician 2011; 84, 1390-1391. PMID: 22230274
6. Simasek M, Blandino DA. Treatment of the common cold. American Family Physician 2007; 75, 515-20. PMID: 17323712
7. Van Cauwenberge P, Berdeaux G, Morineau A, Smadja C, Allaire JM. Use of diagnostic clusters to assess the economic consequences of rhinopharyngitis in children in Italy and France during the winter. Rhinitis Survey Group. Clin Ther 1999; 21, 404-421. PMID: 10211541
8. Heikkinen T, Järvinen A. The common cold Lancet 2003; 361, 51-59. PMID: 12517470
9. Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev 3, CD006362, 2009. doi: 10.1002/14651858.CD006362.pub2 PMID: 19588387
10. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 6:CD000247, 2013. doi: 10.1002/14651858.CD000247.pub3 PMID: 23733381
11. Berdeaux G, Hervié C, Smajda C, Marquis P. Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Rhinitis Survey Group. Qual Life Res 1998; 6, 501-12. PMID: 9737140
12. Nichol KL, D'Heilly S, Ehlinger E. Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use. Clin Infect Dis 2005; 40, 1263-1270. PMID: 15825028
13. Cohen JM, Mosnier A, Daviaud I, Grog I. Ecogrippe: combien coÛte la grippe? XIIème Journée Nationale des GROG - Paris, 15 novembre 2007.
14. Berggren A, Lazou Ahren I, Larsson N, Onning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition 2011; 50, 203-210. doi: 10.1007/s00394-010-0127-6 PMID: 20803023
15. Cáceres P, Montes S, Vega N, Cruchet S, Brunser O, Gotteland M. Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases 2010; 5, 353-62.
16. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005; 24, 481-91. PMID: 16054520
17. Guillemard E, Tanguy J, Flavigny A, de la Motte S, Schrezenmeir J, Guillemard E, et al. Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial. J Am Coll Nutr 2010; 29, 455-68. PMID: 21504972
18. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr. 2010; 103, 58-68. doi: 10.1017/S0007114509991395 PMID: 19747410
19. Hojsak I, Abdovic S, Szajewska H, Milosevic M, Krznaric Z, Kolacek S. Lactobacillus GG in the Prevention of Nosocomial Gastrointestinal and Respiratory Tract Infections. Pediatrics 2010; 125, E1171-E7. doi: 10.1542/peds.2009-2568 PMID: 20403940
20. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S, et al. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2010; 29, 312-316. doi: 10.1016/j.clnu.2009.09.008 PMID: 19896252
21. Kekkonen RA, Vasankari TJ, Vuorimaa T, Haahtela T, Julkunen I, Korpela R. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. International Journal of Sport Nutrition & Exercise Metabolism 2007; 17, 352-363.
22. Kloster Smerud H, Ramstad Kleiveland C, Roll Mosland A, Grave G, Birkeland SE. Effect of a probiotic milk product on gastrointestinal and respiratory infections in children attending day-care. Microbial Ecology in Health and Disease 2008; 20, 80-85.
23. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br J Nutr 2009; 101, 1722-1726. doi: 10.1017/S0007114508116282 PMID: 18986600
24. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. Journal of Nutrition, Health & Aging 2003; 7, 75-77.
25. HTAi Interest Sub-Group on the Impact of Public Health interventions, special focus on Nutrition, on Health Outcomes Research and Measurement (INPHORM). Available: http://www.htai.org/index.php?id=782. Accessed 24 March 2015.
26. ISPOR Special Interest Group on medical nutrition products (September 2014). Available: http://www.ispor.org/sigs/MedicalNutrition.aspx. Accessed 24 March 2015.
27. Schlundt J. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. FAO / WHO, 2002.
28. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. doi: 10.1038/nrgastro.2014.66 PMID: 24912386
29. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, et al. Probiotic and Prebiotic Influence Beyond the Intestinal Tract. Nutrition Reviews 2007; 65, 469-489. PMID: 18038940
30. Sanders ME, Lenoir-Wijnkoop I, Salminen S, Merenstein DJ, Gibson GR, Petschow BW, et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann. N.Y. Acad. Sci 2014; 1309, 19-29. doi: 10.1111/nyas.12377 PMID: 24571254
31. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 9, CD006895, 2011. doi: 10.1002/14651858.CD006895.pub2 PMID: 21901706
32. King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. The Effectiveness of Probiotics on Length of Illness in Healthy Children and Adults who Develop Common Acute Respiratory Infectious Conditions: A Systematic Review and Meta-Analysis. British Journal of Nutrition, 2014.
33. Kang EJ, Kim SY, Hwang IH, Ji YJ. The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean J Fam Med. 2013 Jan; 34(1):2-10. doi: 10.4082/kjfm.2013.34.1.2 PMID: 23372900
34. Choix Méthodologiques pour l' évaluation économique à la HAS. Guide Méthodologique. Haute Autoritéde la Santé. Saint Denis la Plaine. France. 2011.
35. Flahault A, Blanchon T, Dorléans Y, Toubiana L, Vibert JF, Valleron AJ. Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res. 2006 Oct; 15(5):413-21, 2006. PMID: 17089946
36. Gueyffier F, Strang CB, Berdeaux G, França LR, Blin P, Massol J, et al. Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions. Therapie 2012; 67, 367-374. doi: 10.2515/therapie/2012042 PMID: 23110837
37. Eurostat website. Available: http://epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search-database. Accessed 24 March 2015.
38. Fleming DM, Ayres JG. Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice. J R Coll Gen Pract 1988; 38, 159-62. PMID: 3265157
39. Benseñor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE, et al. Active and passive smoking and risk of colds in women. Ann Epidemiol 2001; 11, 225-231. PMID: 11306340
40. INSEE: National Institute for Statistics and Economic Studies. Available: http://www.insee.fr/en/. Accessed 24 March 2015.
41. Louhiala PJ, Jaakkola N, Ruotsalainen R, Jaakkola JJ. Form of day care and respiratory infections among Finnish children. Am J Public Health 1995; 85, 1109-12. PMID: 7625505
42. Jaakkola JJ, Heinonen OP. Shared office space and the risk of the common cold. Eur J Epidemiol 1995; 11, 213-216. PMID: 7672078
43. Mosnier A. Place de la prescription antibiotique dans la prise en charge de la grippe. VIIème Journée Nationale des GROG - Paris, 21 novembre 2002. Available: http://www.grog.org/documents/jour-2002/amm2.pdf. Accessed 24 March 2015.
44. Cohen JM, Mosnier A, Grog I. A medical network to scrutinize Influenza epidemics ("La surveillance de la grippe en France"). Medecine sciences 2003; 19, 239-242. Available: http://www.erudit.org/revue/ms/2003/v19/n2/000694ar.pdf. Accessed 24 March 2015. PMID: 12836619
45. BdM-IT. Base des médicaments, informations tarifaires. Available: www.ameli.fr. Accessed 24 March 2015.
46. Cour des comptes. Les arrêts de travail et les indemnités journalières versées au titre de la maladie. 22/11/12 - Rapport de la Cour des comptes juillet 2012. Available: http://www.assemblee-nationale.fr/14/budget/mecss/cc-juillet2012.pdf. Accessed 24 March 2015.
47. Grippenet résultats saison 2011-2012. Available: https://www.grippenet.fr/fr/resultats/premiere-saison/. Accessed 24 March 2015.
48. Vingilis E, Brown U, Hennen B. Common colds. Reported patterns of self-care and health care use. Can Fam Physician 1999; 45:2644-6, 2649-52. PMID: 10587772
49. Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med 2002; 44, 822-829. PMID: 12227674
50. Pitman RJ, Nagy LD, Sculpher MJ. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Vaccine. 2013 Jan 30; 31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010 PMID: 23246550
51. Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med. 2013 Oct; 10(10):e1001527. doi: 10.1371/journal.pmed.1001527 PMID: 24115913
52. Viboud C, Boëlle PY, Cauchemez S, Lavenu A, Valleron AJ, Flahault A, et al. Risk factors of influenza transmission in households. Br J Gen Pract. 2004 Sep; 54(506):684-9. PMID: 15353055
53. Busse PJ, Mathur SK. Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol. 2010 Oct; 126(4):690-9; quiz 700-1. doi: 10.1016/j.jaci.2010.08.011 PMID: 20920759
54. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Syst Rev 7, CD006207, 2011.